Acumen Pharmaceuticals ABOS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q3 | 2.48 | 112.27 | -0.50 | -32,265 | -30 | |
| 2024Q2 | 2.42 | 124.82 | -0.34 | -24,381 | -21 | |
| 2024Q1 | 4.05 | 128.12 | -0.25 | -17,774 | -15 | |
| 2023Q4 | 3.84 | 116.15 | -0.29 | -18,486 | -16 | |
| 2023Q3 | 4.15 | 123.79 | -0.23 | -16,039 | -13 | |
| 2023Q2 | 4.81 | 116.09 | -0.28 | -13,478 | -12 | |
| 2023Q1 | 4.06 | 116.17 | -0.28 | -13,135 | -11 | |
| 2022Q4 | 5.40 | 110.74 | -0.32 | -14,248 | -13 | |
| 2022Q3 | 10.03 | 106.17 | -0.26 | -11,371 | -11 | |
| 2022Q2 | 4.70 | 102.57 | -0.25 | -10,412 | -10 | |
| 2022Q1 | 3.91 | 100.84 | -0.23 | -9,206 | -9 | |
| 2021Q4 | 6.76 | 100.79 | 1.98 | -8,415 | -8 | |
| 2021Q3 | 14.86 | 101.44 | 200.52 | -3,935 | -4 | |
| 2021Q2 | 5.61 | -143.11 | -3,441 | -61 | ||
| 2021Q1 | 14.05 | -64.41 | -3,793 | -27 | ||
| 2020Q4 | -1,341 | -1 | ||||
| 2020Q3 | -2,490 | -2 | ||||
| 2020Q2 | -0.07 | -2,035 | -2 |